Science and Research
Artificial intelligence research
CERA scientists are at the forefront of artificial intelligence research, developing and applying innovative technologies to detect and better understand eye disease.
Why this research is important
Artificial intelligence is changing the future landscape of medicine and medical research, and ophthalmology is at the forefront.
CERA researchers are demonstrating that AI technologies have the potential to make eye screening more accessible and convenient for patients, and to help doctors predict the progression of eye disease.
This could allow for more cost-effective care, reduce stressful workloads for clinicians, and provide more flexibility and empowerment for patients. It can also play a vital role in helping to close the gap in eye health care, bringing services to remote communities where access to eye specialists is often scarce.
Professor Peter van Wijngaarden
Professor Peter van Wijngaarden is an ophthalmologist and medical scientist with research interests in diabetic retinopathy, Alzheimer’s disease and retinal imaging biomarker discovery. He has research experience in retinal vascular biology and central nervous system regeneration.
Associate Professor Zhichao Wu
Associate Professor Zhichao Wu is a clinician-scientist who leads CERA’s clinical biomarkers research, whose research focuses on expediting the discovery of new treatments and prevention of irreversible vision loss from conditions such as age-related macular degeneration and glaucoma.